These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 7521109)
1. [Role of growth factors in the etiopathogenesis of benign prostatic hyperplasia]. Blanco Jiménez E; Moreno Sierra J; Fernández Lucas C; Begara Morillas F; Hermida Gutiérrez J; Resel Estévez L Actas Urol Esp; 1994 May; 18 Suppl():359-64. PubMed ID: 7521109 [TBL] [Abstract][Full Text] [Related]
2. [Peptide growth factors in the prostate]. Tatoud R; Desgrandchamps F; DeGeorges A; Thomas F Pathol Biol (Paris); 1993 Oct; 41(8):731-40. PubMed ID: 7507232 [TBL] [Abstract][Full Text] [Related]
3. Review of peptide growth factors in benign prostatic hyperplasia and urological malignancy. Steiner MS J Urol; 1995 Apr; 153(4):1085-96. PubMed ID: 7532724 [No Abstract] [Full Text] [Related]
4. Polypeptide modulators of prostatic growth and development. Story MT Cancer Surv; 1991; 11():123-46. PubMed ID: 1726787 [TBL] [Abstract][Full Text] [Related]
5. [Regulation of prostatic growth and function by polypeptide growth factors]. Wu SF; Tu ZH Sheng Li Ke Xue Jin Zhan; 2002 Jan; 33(1):56-8. PubMed ID: 12001734 [No Abstract] [Full Text] [Related]
6. Regulation of prostatic growth and function by peptide growth factors. Culig Z; Hobisch A; Cronauer MV; Radmayr C; Hittmair A; Zhang J; Thurnher M; Bartsch G; Klocker H Prostate; 1996 Jun; 28(6):392-405. PubMed ID: 8650077 [TBL] [Abstract][Full Text] [Related]
7. [Prostatic growth factors and benign hypertrophy of the prostate. Current knowledge and perspectives]. Desgrandchamps F; Tatoud R; Cussenot O; Teillac P; Le Duc A Prog Urol; 1992 Dec; 2(6):1031-44. PubMed ID: 1284554 [TBL] [Abstract][Full Text] [Related]
8. Regulation of basic fibroblast growth factor expression by transforming growth factor beta in cultured human prostate stromal cells. Story MT; Hopp KA; Meier DA Prostate; 1996 Apr; 28(4):219-26. PubMed ID: 8602397 [TBL] [Abstract][Full Text] [Related]
9. [Growth factors and benign prostatic hyperplasia]. Boroian R Georgian Med News; 2007 Nov; (152):18-22. PubMed ID: 18175827 [TBL] [Abstract][Full Text] [Related]
10. Heparin-binding epidermal growth factor-like growth factor is an autocrine mediator of human prostate stromal cell growth in vitro. Duque JL; Adam RM; Mullen JS; Lin J; Richie JP; Freeman MR J Urol; 2001 Jan; 165(1):284-8. PubMed ID: 11125426 [TBL] [Abstract][Full Text] [Related]
11. Expression analysis of peptide growth factors VEGF, FGF2, TGFB1, EGF and IGF1 in prostate cancer and benign prostatic hyperplasia. Soulitzis N; Karyotis I; Delakas D; Spandidos DA Int J Oncol; 2006 Aug; 29(2):305-14. PubMed ID: 16820871 [TBL] [Abstract][Full Text] [Related]
14. Growth factor regulation of gene expression in the human prostatic carcinoma cell line LNCaP. Henttu P; Vihko P Cancer Res; 1993 Mar; 53(5):1051-8. PubMed ID: 7679946 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical comparative analysis of transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates. De Miguel P; Royuela ; Bethencourt R; Ruiz A; Fraile B; Paniagua R Cytokine; 1999 Sep; 11(9):722-7. PubMed ID: 10479409 [TBL] [Abstract][Full Text] [Related]
16. The role of growth factors in the pathogenesis of BPH. Habib FK Prog Clin Biol Res; 1994; 386():43-50. PubMed ID: 7528412 [No Abstract] [Full Text] [Related]
17. Role of peptide growth factors in the prostate: a review. Steiner MS Urology; 1993 Jul; 42(1):99-110. PubMed ID: 7687082 [No Abstract] [Full Text] [Related]